In this study, we used the tail vein method of AAV9-cTNT-CDC20 to prove that overexpression of CDC20 can inhibit DOX-induced myocardial injury in mice, thereby reducing the development of heart failure in mice, and without affecting the antitumor effect of DOX. The gene discussed is CDC20; the disease is heart failure.